Literature DB >> 12794134

Characterization and analysis of the proximal Janus kinase 3 promoter.

Martin Aringer1, Sigrun R Hofmann, David M Frucht, Min Chen, Michael Centola, Akio Morinobu, Roberta Visconti, Daniel L Kastner, Josef S Smolen, John J O'Shea.   

Abstract

Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase essential for signaling via cytokine receptors that comprise the common gamma-chain (gammac), i.e., the receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Jak3 is preferentially expressed in hemopoietic cells and is up-regulated upon cell differentiation and activation. Despite the importance of Jak3 in lymphoid development and immune function, the mechanisms that govern its expression have not been defined. To gain insight into this issue, we set out to characterize the Jak3 promoter. The 5'-untranslated region of the Jak3 gene is interrupted by a 3515-bp intron. Upstream of this intron and the transcription initiation site, we identified an approximately 1-kb segment that exhibited lymphoid-specific promoter activity and was responsive to TCR signals. Truncation of this fragment revealed that core promoter activity resided in a 267-bp fragment that contains putative Sp-1, AP-1, Ets, Stat, and other binding sites. Mutation of the AP-1 sites significantly diminished, whereas mutation of the Ets sites abolished, the inducibility of the promoter construct. Chromatin immunoprecipitation assays showed that histone acetylation correlates with mRNA expression and that Ets-1/2 binds this region. Thus, transcription factors that bind these sites, especially Ets family members, are likely to be important regulators of Jak3 expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794134     DOI: 10.4049/jimmunol.170.12.6057

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Transcriptional regulation of murine natural killer cell development, differentiation and maturation.

Authors:  Werner Held; Beena Jeevan-Raj; Mélanie Charmoy
Journal:  Cell Mol Life Sci       Date:  2018-06-29       Impact factor: 9.261

2.  An alternative NFAT-activation pathway mediated by IL-7 is critical for early thymocyte development.

Authors:  Amiya K Patra; Andris Avots; René P Zahedi; Thomas Schüler; Albert Sickmann; Ursula Bommhardt; Edgar Serfling
Journal:  Nat Immunol       Date:  2012-12-23       Impact factor: 25.606

Review 3.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

Review 4.  Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates.

Authors:  Adriana Coricello; Francesco Mesiti; Antonio Lupia; Annalisa Maruca; Stefano Alcaro
Journal:  Molecules       Date:  2020-07-22       Impact factor: 4.411

5.  Pharmacophore-Based Virtual Screening and Experimental Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases.

Authors:  Kamonpan Sanachai; Panupong Mahalapbutr; Kowit Hengphasatporn; Yasuteru Shigeta; Supaphorn Seetaha; Lueacha Tabtimmai; Thierry Langer; Peter Wolschann; Tanakorn Kittikool; Sirilata Yotphan; Kiattawee Choowongkomon; Thanyada Rungrotmongkol
Journal:  ACS Omega       Date:  2022-09-06

6.  Regulation of murine natural killer cell commitment.

Authors:  Nicholas D Huntington; Stephen L Nutt; Sebastian Carotta
Journal:  Front Immunol       Date:  2013-01-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.